• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

搜索参数和标准对化合物选择、混杂性和泛分析干扰特征的影响。

Influence of search parameters and criteria on compound selection, promiscuity, and pan assay interference characteristics.

机构信息

Department of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität , Dahlmannstr. 2, D-53113 Bonn, Germany.

出版信息

J Chem Inf Model. 2014 Nov 24;54(11):3056-66. doi: 10.1021/ci5005509. Epub 2014 Oct 31.

DOI:10.1021/ci5005509
PMID:25329977
Abstract

Compound activity data grow at unprecedented rates, and their complexity increases. This challenges compound data mining efforts and makes it difficult to draw reliable conclusions from data analysis. We have aimed to investigate the influence of individual parameters and data confidence levels on compound selection and property assessment. Therefore, alternative sets of bioactive compounds were systematically extracted from ChEMBL on the basis of iteratively expanding selection criteria with increasing stringency covering a variety of search parameters. The sequential application of criteria for the selection of high-confidence compound data was order-independent, as expected. Furthermore, the influence of separately applied selection criteria was analyzed. Criteria that largely influenced compound selection and compound promiscuity rates were identified. In the presence of stringent selection criteria and high data confidence, many compounds with likely assay artifacts or liabilities were eliminated from further consideration. Taken together, the findings of our analysis emphasize the need to carefully consider search parameters related to target organisms, confidence level of activity, and activity measurements and suggest reliable protocols for compound data mining.

摘要

化合物活性数据以前所未有的速度增长,其复杂性也在增加。这给化合物数据挖掘工作带来了挑战,使得从数据分析中得出可靠的结论变得困难。我们旨在研究个体参数和数据置信度水平对化合物选择和性质评估的影响。因此,根据不断提高的严格程度,我们从 ChEMBL 中系统地提取了一系列替代的生物活性化合物,涵盖了各种搜索参数。正如预期的那样,选择高置信度化合物数据的标准的顺序是独立的。此外,我们还分析了单独应用选择标准的影响。确定了对化合物选择和化合物混杂率有较大影响的标准。在严格的选择标准和高数据置信度的情况下,许多可能存在测定假象或缺陷的化合物被排除在进一步考虑之外。总的来说,我们分析结果强调需要仔细考虑与目标生物、活性置信度以及活性测量相关的搜索参数,并为化合物数据挖掘提出可靠的方案。

相似文献

1
Influence of search parameters and criteria on compound selection, promiscuity, and pan assay interference characteristics.搜索参数和标准对化合物选择、混杂性和泛分析干扰特征的影响。
J Chem Inf Model. 2014 Nov 24;54(11):3056-66. doi: 10.1021/ci5005509. Epub 2014 Oct 31.
2
Growth of ligand-target interaction data in ChEMBL is associated with increasing and activity measurement-dependent compound promiscuity.ChEMBL 中配体-靶标相互作用数据的增长与化合物的普遍反应性(即与多种靶点相互作用的能力)的增加和基于活性的测量方法有关。
J Chem Inf Model. 2012 Oct 22;52(10):2550-8. doi: 10.1021/ci3003304. Epub 2012 Sep 28.
3
Compound promiscuity: what can we learn from current data?化合物混杂性:我们能从现有数据中学到什么?
Drug Discov Today. 2013 Jul;18(13-14):644-50. doi: 10.1016/j.drudis.2013.03.002. Epub 2013 Mar 22.
4
Large-scale similarity search profiling of ChEMBL compound data sets.大规模相似性搜索分析 ChEMBL 化合物数据集。
J Chem Inf Model. 2011 Aug 22;51(8):1831-9. doi: 10.1021/ci200199u. Epub 2011 Jul 14.
5
Compound Data Mining for Drug Discovery.用于药物发现的复合数据挖掘
Methods Mol Biol. 2017;1526:247-256. doi: 10.1007/978-1-4939-6613-4_14.
6
Identification of orthologous target pairs with shared active compounds and comparison of organism-specific activity patterns.鉴定具有共享活性化合物的直系同源靶点对,并比较特定生物体的活性模式。
Chem Biol Drug Des. 2015 Nov;86(5):1105-14. doi: 10.1111/cbdd.12578. Epub 2015 May 18.
7
Systematic assessment of compound series with SAR transfer potential.具有 SAR 转移潜力的化合物系列的系统评估。
J Chem Inf Model. 2012 Dec 21;52(12):3138-43. doi: 10.1021/ci300481d. Epub 2012 Dec 6.
8
Evolution of the activity cliff concept for structure-activity relationship analysis and drug discovery.用于构效关系分析和药物发现的活性悬崖概念的演变
Future Med Chem. 2014 Sep;6(14):1545-9. doi: 10.4155/fmc.14.94.
9
Analyzing Promiscuity at the Level of Active Compounds and Targets.从活性化合物和靶点层面分析滥交现象。 不过需要说明的是,这里“promiscuity”在医学语境中可能不是常见含义,结合上下文可能有更准确的理解,仅按字面翻译是这样。
Mol Inform. 2016 Dec;35(11-12):583-587. doi: 10.1002/minf.201600030. Epub 2016 Apr 28.
10
From activity cliffs to activity ridges: informative data structures for SAR analysis.从活动崖到活动脊:SAR 分析的信息数据结构。
J Chem Inf Model. 2011 Aug 22;51(8):1848-56. doi: 10.1021/ci2002473. Epub 2011 Aug 4.

引用本文的文献

1
Identification of New Toxicity Mechanisms in Drug-Induced Liver Injury through Systems Pharmacology.通过系统药理学鉴定药物性肝损伤的新毒性机制。
Genes (Basel). 2022 Jul 21;13(7):1292. doi: 10.3390/genes13071292.
2
Probabilistic Random Forest improves bioactivity predictions close to the classification threshold by taking into account experimental uncertainty.概率随机森林通过考虑实验不确定性,改进了接近分类阈值的生物活性预测。
J Cheminform. 2021 Aug 19;13(1):62. doi: 10.1186/s13321-021-00539-7.
3
Large-Scale Comparison of Alternative Similarity Search Strategies with Varying Chemical Information Contents.
具有不同化学信息含量的替代相似性搜索策略的大规模比较。
ACS Omega. 2019 Sep 5;4(12):15304-15311. doi: 10.1021/acsomega.9b02470. eCollection 2019 Sep 17.
4
SuperDRUG2: a one stop resource for approved/marketed drugs.SuperDRUG2:已批准/上市药物的一站式资源。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1137-D1143. doi: 10.1093/nar/gkx1088.
5
WITHDRAWN--a resource for withdrawn and discontinued drugs.撤回——关于撤市和停用药物的资源。
Nucleic Acids Res. 2016 Jan 4;44(D1):D1080-6. doi: 10.1093/nar/gkv1192. Epub 2015 Nov 8.
6
Strong nonadditivity as a key structure-activity relationship feature: distinguishing structural changes from assay artifacts.强非加和性作为关键的构效关系特征:区分结构变化与检测假象。
J Chem Inf Model. 2015 Mar 23;55(3):483-94. doi: 10.1021/acs.jcim.5b00018. Epub 2015 Mar 11.
7
Structural and Activity Profile Relationships Between Drug Scaffolds.药物支架的结构和活性谱关系
AAPS J. 2015 May;17(3):609-19. doi: 10.1208/s12248-015-9737-5. Epub 2015 Feb 20.